Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NXGL
NXGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NXGL News
NEXGEL Schedules Q4 and FY 2025 Earnings Call
6d ago
Newsfilter
NEXGEL INC - Agreement Anticipated to Increase Annual Revenue to $35 Million and Achieve Profitability at Closing
Mar 12 2026
moomoo
NEXGEL INC: $15 Million Upfront Cash and Potential $20 Million in Milestone Payments Included in Consideration
Mar 12 2026
moomoo
NEXGEL Reveals Terms for Licensing and Acquiring a Portfolio of Commercial Regenerative Biomaterial Products
Mar 12 2026
moomoo
Celularity Forms Strategic Partnership with NEXGEL
Mar 12 2026
Globenewswire
NexGel Expects Revenue to Triple
Mar 10 2026
Benzinga
NEXGEL INC ANTICIPATES COMPLETING $14.9 MILLION IN EXTRA FINANCING BY Q1 OR EARLY Q2 2026
Mar 10 2026
moomoo
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
Mar 10 2026
Benzinga
NEXGEL Secures $1.797 Million Financing for Potential Acquisition
Feb 10 2026
Newsfilter
NEXGEL's NexGelRx Secures Investment and Strategic Advisor Appointment
Dec 16 2025
Newsfilter
Nexgel Revenue Jumps 100% in Fiscal Q2
Aug 13 2025
NASDAQ.COM
NEXGEL, Inc. (NXGL) Q2 2025 Earnings Call Transcript
Aug 12 2025
Newsfilter
NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement
Aug 01 2025
Newsfilter
NEXGEL and STADA AG Announce Expansion of Partnership for North America
Jul 14 2025
Newsfilter
NEXGEL to Participate in the 6th Annual CEO Networking Event Hosted by Semco Capital on June 2nd
May 21 2025
Newsfilter
NEXGEL to Report First Quarter 2025 Financial Results on May 13th
May 09 2025
Newsfilter
Show More News
